-
Immunotherapy Highlights From the 2011 Meeting of the American Society of Hematology
Read about immunotherapy studies presented at the American Society of Hematology annual meeting on such topics as T-cell function, tumor antigen targeting, and more.
April 30, 2012
-
RNA-based Markers as Prognostic Factors in Chronic Lymphocytic Leukemia
Clinical and molecular markers known to be predictive of prognosis in CLL can be applied to discriminate patients that are more likely to develop a progressive disease.
February 10, 2012
-
A New Era for IFN-Α in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms
This article highlights the current status of interferon-alpha 2 in the treatment of patients with essential thrombocytopenia, polycythemia vera, and more.
December 29, 2011
-
Late-onset Neutropenia Following Rituximab Therapy
Late-onset neutropenia is emerging as a common adverse effect of rituximab when used in the treatment of autoimmune diseases. Is this late effect as widespread as it seems?
November 30, 2011
-
Targeted Molecular Therapy in Peripheral T-Cell Lymphomas
Emerging therapeutic opportunities that could revamp the management of peripheral T-cell lymphomas are reviewed.
October 05, 2011
-
Managing Acute Promyelocytic Leukemia Without Conventional Chemotherapy
Cure rates of APL may be further increased by implementing strategies to reduce early hemorrhagic deaths by educating healthcare providers to recognize the disease early.
August 17, 2011
-
Optimizing the Selection of Kinase Inhibitors for Chronic Myeloid Leukemia Patients
For newly diagnosed chronic phase-CML patients there are multiple treatment options, but the large selection can be confusing. Unravel the mystery.
July 15, 2011
-
Magnetic Resonance Imaging of Malignant Lymphoma
Whole-body MRI and diffusion-weighted imaging may be good radiation-free alternatives to FDG-PET/CT, which could be particularly relevant for children.
May 24, 2011
-
Dose Escalation of Imatinib in Chronic-Phase Chronic Myeloid Leukemia Patients
Suboptimal response or treatment failure to standard-dose imatinib are relevant problems in chronic-phase CML patients, and some will benefit from ramping-up the dose.
May 10, 2011
-
Pain in Malignant Hematology
Pain management in hematology requires a multidisciplinary approach, integrating analgesics and causal interventions.
March 02, 2011
-
Personalizing Treatment for Chronic Lymphocytic Leukemia
New therapeutic agents are desperately needed for patients with refractory CLL.
February 24, 2011
-
Adult T-cell Leukemia-Lymphoma: Current Treatment Strategies and Novel Immunological Approaches
Get up-to-date information on therapies for this aggressive form of NHL.
December 27, 2010
-
Nilotinib is Superior to Imatinib as First-line Therapy of Chronic Myeloid Leukemia: The ENESTnd Study
Nilotinib could take us one step closer to a cure for chronic myeloid leukemia. What makes this first-line therapy so effective?
December 15, 2010
-
Diagnosis and Management of Natural Killer-cell Malignancies
Natural killer cell malignancies may have an unnatural presentation. Find out more about this uncommon neoplasm.
November 24, 2010
-
Plasma Cell Leukemia: Concepts and Management
Plasma cell leukemia, a rare and aggressive form of plasma cell myeloma that is difficult to manage, is discussed in this review.
November 11, 2010
-
Follicular Lymphoma: Emerging Therapeutic Strategies
Promising treatments for follicular lymphoma are discussed in depth along with decision-tree analysis.
October 25, 2010
-
Relapse After Allogeneic Stem Cell Transplantation
Potential causes of treatment failure are discussed along with alternative strategies for retrenching after SCT relapse.
October 11, 2010
-
Novel Treatment Regimens for Waldenström’s Macroglobulinemia
Review the most recent results obtained from the use of new drugs along with their therapeutic associations in patients with Waldenström's macroglobulinemia at different stages of the disease.
September 27, 2010
-
Allogeneic Immunotherapy to Optimize the Graft-Versus-Tumor Effect: Concepts and Controversies
Authors discuss the recent evolution of novel conditioning regimens in combination with adoptive cellular therapy in the allogeneic transplant setting for hematologic malignancies.
September 13, 2010
-
Autologous Hematopoietic Stem Cell Transplantation in Autoimmune Diseases
This article discusses the growing experience in the use of HSCT in various autoimmune diseases, including multiple sclerosis, Crohn’s disease, and systemic sclerosis.
February 23, 2010
